. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Exploratory Data Analysis

David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,707

A simulation study of the number of events per variable in logistic regression analysis

Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488

Exploratory Data Analysis.

Birch, J. B., & Tukey, J. W. (1978) · Journal of the American Statistical Association · doi:10.2307/2286300 · Cited by 1,465

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098

Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women

Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B. L., Merz, C. N. B., Sopko, G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115516.54550.b1 · Cited by 417

Problems due to Small Samples and Sparse Data in Conditional Logistic Regression Analysis

Greenland, S., Schwartzbaum, J., & Finkle, W. D. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010240 · Cited by 367

Riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana en España. Cohorte CoRIS, 2011

Masiá, M., Cachafeiro, S. P., Leyes, M., López‐Aldeguer, J., López, M., Segura, F., Blanco, J. R., Peña, A., Rodríguez, F., Vera, M., et al. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.02.014 · Cited by 25

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case–Cohort Study

Balagopal, A., Asmuth, D. M., Yang, W.-T., Campbell, T., Gupte, N., Smeaton, L. M., Kanyama, C., Grinsztejn, B. G. J., Santos, B. R., Supparatpinyo, K., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000696 · Cited by 25

Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy

Ticona, E., Bull, M. E., Soria, J., Tapia, K. A., Legard, J., Styrchak, S. M., Williams, C. M., Mitchell, C. M., Rosa, A. L., Coombs, R. W., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000758 · Cited by 25

Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study

Barton, J. H., Ireland, A., Fitzpatrick, M. E., Kessinger, C. J., Camp, D., Weinman, R., McMahon, D. K., Leader, J. K., Holguín, F., Wenzel, S. E., et al. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0274-5 · Cited by 24

Acute kidney injury in HIV ‐infected patients: a critical review

Gameiro, J., Fonseca, J. A., Jorge, S., & Lopes, J. (2018) · HIV Medicine · doi:10.1111/hiv.12685 · Cited by 26

HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases

Herrera, S., Martínez‐Sanz, J., & Villar, S. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01466 · Cited by 25

The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes

Scarale, M. G., Copetti, M., Garofolo, M., Fontana, A., Salvemini, L., Cosmo, S. D., Lamacchia, O., Penno, G., Trischitta, V., & Menzaghi, C. (2020) · Diabetes Care · doi:10.2337/dc19-2489 · Cited by 26

Association between Systemic Inflammation and Obstructive Sleep Apnea in Men with or at Risk for HIV Infection

Brigham, E. P., Patil, S. P., Jacobson, L. P., Margolick, J. B., Godfrey, R., Johnson, J. R., Johnson, L., Reynolds, S. M., Schwartz, A. R., Smith, P. L., et al. (2013) · Antiviral Therapy · doi:10.3851/imp2745 · Cited by 25

Complications of HIV disease and antiretroviral treatment.

Luetkemeyer, A. F., Havlir, D. V., & Currier, J. S. (2010) · PubMed · Cited by 25

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide

Funderburg, N., McComsey, G. A., Kulkarni, M., Bannerman, T. L., Mantini, J., Thornton, B., Liu, H. C., Zhang, Y., Song, Q., Fang, L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.009 · Cited by 25

Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance

Neogi, U., Shet, A., Shamsundar, R., & Ekstrand, M. L. (2011) · AIDS · doi:10.1097/qad.0b013e328346269f · Cited by 24

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

Castillo‐Mancilla, J., Phillips, A. N., Neaton, J. D., Neuhaus, J., Collins, S., Mannheimer, S., Pett, S. L., Touzeau‐Römer, V., Polizzotto, M. N., Lundgren, J. D., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx275 · Cited by 24

Aerobic fitness and physical activity are inversely associated with body fat, dyslipidemia and inflammatory mediators in children and adolescents living with HIV

de Lima, L. R. A., Back, I. D. C., Nunes, E. A., Silva, D. A. S., & Petróski, E. L. (2018) · Journal of Sports Sciences · doi:10.1080/02640414.2018.1481724 · Cited by 24

Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients

Liu, K., Huang, H.-H., Yang, T., Jiao, Y., Zhang, C., Song, J., Zhang, J., Zhou, C., Yuan, J., Cao, W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670616 · Cited by 24

Mucosal‐associated invariant T cells: A cryptic coordinator in HIV‐infected immune reconstitution

Su, B., Kong, D., Yang, X., Zhang, T., & Kuang, Y. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27696 · Cited by 24

Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

Clemente, T., Galli, L., Lolatto, R., Gagliardini, R., Lagi, F., Ferrara, S. M., Cattelan, A. M., Focà, E., Biagio, A. D., Cervo, A., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080606 · Cited by 24

Unhealthy Alcohol Use is Associated with Monocyte Activation Prior to Starting Antiretroviral Therapy

Carrico, A. W., Hunt, P. W., Emenyonu, N. I., Muyindike, W. R., Ngabirano, C., Cheng, D. M., Winter, M. R., Samet, J. H., & Hahn, J. A. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12908 · Cited by 24

Relationship Between Poor Physical Function, Inflammatory Markers, and Comorbidities in HIV-Infected Women on Antiretroviral Therapy

Baranoski, A. S., Harris, A., Michaels, D., Miciek, R., Storer, T. W., Paola Sebastiani, B., & Montano, M. A. (2013) · Journal of Women s Health · doi:10.1089/jwh.2013.4367 · Cited by 22

Immunovirological parameters and cytokines in HIV infection

Tasca, K. I., Calvi, S. A., & de Souza, L. D. R. (2012) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822012000600002 · Cited by 24

Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age‐matched controls: Role of cytomegalovirus

Azanan, M. S., Abdullah, N. K., Chua, L. L., Lum, S. H., Ghafar, S. S. A., Kamarulzaman, A., Kamaruzzaman, S. B., Lewin, S. R., Woo, Y. L., Ariffin, H., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201646356 · Cited by 24

Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques

Palesch, D., Bosinger, S. E., Mavigner, M., Billingsley, J. M., Mattingly, C., Carnathan, D. G., Paiardini, M., Chahroudi, A., Vanderford, T. H., & Silvestri, G. (2018) · Journal of Virology · doi:10.1128/jvi.00279-18 · Cited by 24

Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression

Marín-Palma, D., Castro, G. A., Cardona‐Arias, J. A., Inchima, S. U., & Hernández, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01350 · Cited by 24

Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation

Shivakoti, R., Yang, W.-T., Gupte, N., Berendes, S., Rosa, A. L., Cardoso, S. W., Mwelase, N., Kanyama, C., Pillay, S., Samaneka, W. P., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ265 · Cited by 26

HIV and ageing

Fisher, M., & Cooper, V. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834f14fa · Cited by 23

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy

Gaifer, Z., & Boulassel, M. (2020) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325958220979817 · Cited by 23

Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection

Asowata, O. E., Singh, A., Ngoepe, A., Herbert, N. G., Fardoos, R., Reddy, K., Zungu, Y., Nene, F., Mthabela, N., Ramjit, D., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146162 · Cited by 22

The COVID misinfodemic: not new, never more lethal

Apetrei, C., Marx, P. A., Mellors, J. W., & Pandrea, I. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.07.004 · Cited by 29

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States

Zanni, M. V., Foldyna, B., McCallum, S., Burdo, T. H., Looby, S. E. D., Fitch, K. V., Fulda, E. S., Autissier, P., Bloomfield, G. S., Malvestutto, C., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac767 · Cited by 23

Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals

Massanella, M., Ouchi, D., Marfil, S., Llibre, J. M., Puertas, M. C., Buzón, M. J., Richman, D. D., Orna, E., Stevenson, M., Gatell, J. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114142 · Cited by 23

Markers of Inflammation and Mortality in a Cohort of Patients With Alcohol Dependence

Fuster, D., Sanvisens, A., Bolao, F., Zuluaga, P., Rivas, I., Tor, J., & Muga, R. (2015) · Medicine · doi:10.1097/md.0000000000000607 · Cited by 23

The Innate Immune Response in HIV/AIDS Septic Shock Patients: A Comparative Study

Amancio, R. T., Japiassú, A. M., Gomes, R. N., Mesquita, E. C., de Assis, E. F., Medeiros, D. M., Grinsztejn, B. G. J., Bozza, P. T., Castro-Faria, H. C., & Bozza, F. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068730 · Cited by 23

IL-8 Alterations in HIV-1 Infected Children With Disease Progression

Pananghat, A. N., Aggarwal, H., Prakash, S. S., Makhdoomi, M. A., Singh, R., Lodha, R., Ali, S., Srinivas, M., Das, B. K., Pandey, R. M., et al. (2016) · Medicine · doi:10.1097/md.0000000000003734 · Cited by 23

A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients

Banach, M., Dinca, M., Ursoniu, S., Șerban, M.-C., Howard, G., Mikhailidis, D. P., Nicholls, S. J., Lip, G. Y. H., Glasser, S. P., Martin, S. S., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.005 · Cited by 23

Cytomegalovirus and paediatric HIV infection

Slyker, J. A. (2016) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30873-6 · Cited by 26

Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis

Bhargavan, B., & Kanmogne, G. D. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0382-0 · Cited by 24

Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection

Shive, C. L., Judge, C. J., Clagett, B. M., Kalayjian, R. C., Osborn, M. K., Sherman, K. E., Fichtenbaum, C. J., Gandhi, R. T., Kang, M., Popkin, D. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.12.018 · Cited by 22

Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda

North, C. M., Muyanja, D. M., Kakuhikire, B., Tsai, A. C., Tracy, R. P., Hunt, P. W., Kwon, D. S., Christiani, D. C., Okello, S., & Siedner, M. J. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001711 · Cited by 22

Long-term risk of mortality for acute kidney injury in HIV-infected patients: a cohort analysis

Lopes, J. A., Melo, M. J., Raimundo, M. R., Fragoso, A., & Antunes, F. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-32 · Cited by 23

Serious Non-AIDS Conditions in HIV: Benefit of Early ART

Lundgren, J. D., Borges, Á. H., & Neaton, J. D. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0387-y · Cited by 26

Coronary heart disease in people infected with HIV

Malvestutto, C., & Aberg, J. A. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09119 · Cited by 22

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels

Hamlyn, E., Stöhr, W., Cooper, D. A., Fisher, M., Tambussi, G., Schechter, M., Miró, J. M., Vanobberghen, F. M., Babiker, A. G., Weber, J. N., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000675 · Cited by 22

Will expanded ART use reduce the burden of HIV-associated chronic lung disease?

Kunisaki, K. M. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000018 · Cited by 22

Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy

Taiwo, B., Matining, R. M., Zheng, L., Lederman, M. M., Rinaldo, C. R., Kim, P. S., Berzins, B. I., Kuritzkes, D. R., Jennings, A., Eron, J. J., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt120 · Cited by 22

Regulatory T Cells in HIV-1 Infection: The Good, the Bad, and the Ugly

Imamichi, H., & Lane, H. C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis238 · Cited by 22

Hemostatic changes associate with mortality in hospitalized patients with HIV-associated tuberculosis: a prospective cohort study

Janssen, S., Schutz, C., Ward, A. M., Huson, M. A., Wilkinson, R. J., Burton, R., Maartens, G., Wilkinson, K. A., Meijers, J. C. M., Lutter, R., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw532 · Cited by 22

Etiology and pathophysiology of heart failure in people with HIV

Choi, H., Dey, A. K., Sharma, G., Bhoite, R. R., Burkholder, G., Fedson, S., & Jneid, H. M. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10048-8 · Cited by 22

Increased Platelet-CD4+ T Cell Aggregates Are Correlated With HIV-1 Permissiveness and CD4+ T Cell Loss

Dai, X., Wu, F.-Y., Cui, C., Liao, X., Jiao, Y., Zhang, C., Song, J., Fan, X., Zhang, J., He, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.799124 · Cited by 22

Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals

Caetano, D. G., Alves, M. R., Hottz, E. D., Villela, L. M., Cardoso, S. W., Hoagland, B., Grinsztejn, B. G. J., Veloso, V. G., Morgado, M. G., Bozza, P. T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10330-9 · Cited by 19

Adiponectin and Interleukin-6, but not Adipose Tissue, are Associated with Worse Neurocognitive Function in HIV-Infected Men

Lake, J. E., Vo, Q., Jacobson, L. P., Sacktor, N. C., Miller, E. N., Post, W. S., Becker, J. T., Palella, F. J., Ragin, A. B., Martin, E. M., et al. (2015) · Antiviral Therapy · doi:10.3851/imp2952 · Cited by 22

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy

Mehraj, V., Jenabian, M.-A., Vyboh, K., & Routy, J. (2014) · The Open AIDS Journal · doi:10.2174/1874613601408010066 · Cited by 22

Arterial Stiffness Evaluation in HIV-Positive Patients: A Multicenter Matched Control Study

Ferraioli, G., Tinelli, C., Maggi, P., Gervasoni, C., Grima, P., Višković, K., Carerj, S., Filice, G., Fìlice, C., & the Arterial Stiffness Evaluation in HIV-Infected Subjects Study Group (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6712 · Cited by 22

Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings

Shivakoti, R., Yang, W.-T., Berendes, S., Mwelase, N., Kanyama, C., Pillay, S., Samaneka, W. P., Santos, B. R., Poongulali, S., Tripathy, S. P., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv573 · Cited by 23

HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer

Taylor, B. S., So‐Armah, K., Tate, J. P., Marconi, V. C., Koethe, J. R., Bedimo, R., Butt, A. A., Gibert, C. L., Goetz, M. B., Rodriguez‐Barradas, M. C., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001444 · Cited by 23

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals

Juega, J., Bonjoch, A., Pérez‐Álvarez, N., Negredo, E., Bayés, B., Bonet, J., Clotet, B., & Romero, R. (2017) · Medicine · doi:10.1097/md.0000000000007421 · Cited by 22

The ‘COmorBidity in Relation to AIDS’ (COBRA) cohort: Design, methods and participant characteristics

Francesco, D. D., Wit, F. W. N. M., Cole, J. H., Kootstra, N. A., Winston, A., Sabin, C. A., Underwood, J., van Zoest, R. A., Schouten, J., Kooij, K. W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191791 · Cited by 23

Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness

Hottz, E. D., Quirino-Teixeira, A. C., de Souza, R. V., Zimmerman, G. A., Bozza, F. A., & Bozza, P. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43275-7 · Cited by 22

Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study

Malo, A. I., Rull, A., Girona, J., Domingo, P., Fuertes-Martín, R., Amigó, N., Rodríguez-Borjabad, C., Martínez-Micaelo, N., Leal, M., Peraire, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051344 · Cited by 23

Venous thromboembolism in people living with HIV infection (PWH)

Agrati, C., Mazzotta, V., Pinnetti, C., Biava, G., & Bibas, M. (2020) · Translational research · doi:10.1016/j.trsl.2020.07.007 · Cited by 22

5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice – Operations research

Kort, R. (2010) · Journal of the International AIDS Society · doi:10.1186/1758-2652-13-s1-s5 · Cited by 21

Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues

Rothenberger, M. K., Nganou‐Makamdop, K., Kityo, C. M., Ssali, F. N., Chipman, J. G., Beilman, G. J., Hoskuldsson, T., Anderson, J. L., Jasurda, J. S., Schmidt, T. E., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002026 · Cited by 22

Evidence-based review of statin use in patients with HIV on antiretroviral therapy

Chastain, D. B., Stover, K. R., & Riche, D. M. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.01.004 · Cited by 54

HIV-1 Infected Lymphoid Organs Upregulate Expression and Release of the Cleaved Form of uPAR That Modulates Chemotaxis and Virus Expression

Nebuloni, M., Zawada, L., Ferri, A., Tosoni, A., Zerbi, P., Resnati, M., Poli, G., Genovese, L., & Alfano, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070606 · Cited by 21

Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial

Kent, S. J., Hough, S., Kelleher, A. D., Law, M. G., Hutchinson, J. L., Catálfamo, M., van Bockel, D. J., Lane, C., Baker, J. V., & Emery, S. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30214-5 · Cited by 21

Sex Differences in the Treatment of HIV

Cohn, J., Ake, J. A., Moorhouse, M. A., & Godfrey, C. C. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00499-x · Cited by 22

Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors

Bratt, G., Brännström, J., Missalidis, C., & Nyström, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254079 · Cited by 21

Elevated inflammatory fecal immune factors in men who have sex with men with HIV associate with microbiome composition and gut barrier function

Littlefield, K. M., Schneider, J. M., Neff, C. P., Soesanto, V., Siebert, J., Nusbacher, N. M., Moreno-Huizar, N., Cartwright, I. M., Armstrong, A. J. S., Colgen, S. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1072720 · Cited by 22

Increased Systemic Inflammation is Associated with Cardiac and Vascular Dysfunction over the First 12 Weeks of Antiretroviral Therapy among Undernourished, HIV-Infected Adults in Southern Africa

Bestawros, M. T. (2015) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000431 · Cited by 21

The role of T cells in the development of cardiovascular disease in HIV-infected patients

Krikke, M., van Lelyveld, S. F. L., Tesselaar, K., Arends, J. E., Hoepelman, I. M., & Visseren, F. L. J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.054 · Cited by 21

Role of liver transplantation in human immunodeficiency virus positive patients

Joshi, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12311 · Cited by 21

Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy

Kaplan‐Lewis, E., Aberg, J. A., & Lee, M.-K. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0331-y · Cited by 21

High prevalence of “non-dipping” blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals

Borkum, M. S., Heckmann, J. M., Manning, K., Dave, J. A., Levitt, N. S., Rayner, B. L., & Wearne, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185003 · Cited by 21

Antibody-Mediated CD4 Depletion Induces Homeostatic CD4 + T Cell Proliferation without Detectable Virus Reactivation in Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Infected Macaques

Kumar, N., McBrien, J. B., Carnathan, D. G., Mavigner, M., Mattingly, C., White, E., Viviano, F., Bosinger, S. E., Chahroudi, A., Silvestri, G., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01235-18 · Cited by 21

The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging

Shiau, S., Bender, A. A., O’Halloran, J. A., Sundermann, E. E., Aggarwal, J., Althoff, K. N., Baker, J. V., Deeks, S. G., Fried, L. P., Karpiak, S. E., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0128 · Cited by 23

European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy

Guzmán, M. G., Berenguer, J., Micheloud, D., Fernández‐Rodríguez, A., García–Álvarez, M., Jiménez‐Sousa, M. Á., Bellón, J. M., Campos, Y., Cosín, J., Aldámiz‐Echevarría, T., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt206 · Cited by 21

Disparities and Trends in Viral Suppression During a Transition to a “Test and Treat” Approach to the HIV Epidemic, San Francisco, 2008–2012

Schwarcz, S. K., Hsu, L. C., & Scheer, S. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000794 · Cited by 20

HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy

Costiniuk, C. T., & Jenabian, M.-A. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0173 · Cited by 21

Effects of 96 Weeks of Rosuvastatin on Bone, Muscle, and Fat in HIV-Infected Adults on Effective Antiretroviral Therapy

Erlandson, K. M., Jiang, Y., Debanne, S. M., & McComsey, G. A. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0191 · Cited by 20

Effect of Maraviroc on HIV Disease Progression-Related Biomarkers

Romero-Sánchez, M. C., Machmach, K., González‐Serna, A., Genebat, M., Pulido, I., García-García, M., Álvarez‐Ríos, A. I., Ferrando‐Martínez, S., Ruíz-Mateos, E., & Leal, M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01406-12 · Cited by 20

The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment‐naïve, asymptomatic HIV ‐infected individuals

Nkambule, B. B., Davison, G. M., & Ipp, H. (2014) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12307 · Cited by 20

Effects of paediatric HIV infection on childhood vasculature

Idris, N. S., Grobbee, D. E., Burgner, D. P., Cheung, M. M. H., Kurniati, N., & Uiterwaal, C. S. P. M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv702 · Cited by 20

Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa

Wong, M., Shiau, S., Yin, M. T., Strehlau, R., Patel, F., Coovadia, A. H., Micklesfield, L. K., Kuhn, L., & Arpadi, S. M. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.01.034 · Cited by 20

Rate and Predictors of Carotid Artery Intima Media Thickness Progression in Antiretroviral-Naive HIV-Infected and Uninfected Adults: A 48-Week Matched Prospective Cohort Study

Hileman, C. O., Carman, T. L., Longenecker, C. T., Labbato, D. E., Storer, N. J., White, C. A., & McComsey, G. A. (2013) · Antiviral Therapy · doi:10.3851/imp2651 · Cited by 20

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

Prendergast, A. J., Szubert, A. J., Berejena, C., Pimundu, G., Pala, P., Shonhai, A., Musiime, V., Bwakura‐Dangarembizi, M., Poulsom, H., Hunter, P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw148 · Cited by 20

Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls

den Dries, L. V., Claassen, M. A. A., Groothuismink, Z. M. A., Gorp, E. C. M. V., & Boonstra, A. (2017) · Virology · doi:10.1016/j.virol.2017.06.014 · Cited by 20

Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals

Wang, R., Haberlen, S., Palella, F. J., Mugavero, M. J., Margolick, J. B., Macatangay, B. J. C., Martı́nez-Maza, O., Jacobson, L. P., & Abraham, A. G. (2018) · AIDS · doi:10.1097/qad.0000000000001986 · Cited by 20

Coronary Artery Disease in Patients with HIV Infection: An Update

Patel, A., & Budoff, M. J. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-020-00451-9 · Cited by 21

Social Isolation Is Linked to Inflammation in Aging People With HIV and Uninfected Individuals

Ellis, R. J., Iudicello, J., Sun-Suslow, N., Grelotti, D. J., Cherner, M., Morgan, E. E., Letendre, S. L., & Heaton, R. K. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002596 · Cited by 21

HIV and the kidney

Bruggeman, L. A., Bark, C., & Kalayjian, R. C. (2009) · Current Infectious Disease Reports · doi:10.1007/s11908-009-0069-4 · Cited by 20

A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy

Canipe, A., Chidumayo, T., Blevins, M. L., Bestawros, M. T., Bala, J., Kelly, P. M., Filteau, S., Shepherd, B. E., Heimburger, D. C., & Koethe, J. R. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-521 · Cited by 20

Macropinocytosis and TAK1 mediate anti-inflammatory to pro-inflammatory macrophage differentiation by HIV-1 Nef

Hashimoto, M., Nasser, H., Chihara, T., & Suzu, S. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.233 · Cited by 20

Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy

Butler, S. L., Valdez, H., Westby, M., Perros, M., June, C. H., Jacobson, J. M., Lévy, Y., Cooper, D. A., Douek, D. C., Lederman, M. M., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31822ccfcc · Cited by 19

Treatment-for-prevention

Lockman, S., & Sax, P. E. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834fcf6b · Cited by 19

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Schnittman, S. R., Byakwaga, H., Boum, Y., Kabakyenga, J. K., Matthews, L. T., Burdo, T. H., Huang, Y., Tracy, R. P., Haberer, J. E., Kembabazi, A., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab245 · Cited by 19

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

Villar, S. S., López‐Huertas, M. R., Jiménez, D., Galera, C., Martínez‐Sanz, J., Moreno, E., Muriel, A., Gutiérrez, F., Busca, C., Portilla, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848630 · Cited by 19

Associations between HIV viremia during antiretroviral therapy and cardiovascular disease

Elvstam, O., Marrone, G., Engström, G., Nilsson, P. M., Carlander, C., Treutiger, C. J., Gisslén, M., & Björkman, P. (2022) · AIDS · doi:10.1097/qad.0000000000003240 · Cited by 19

The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses

Teer, E., Mukonowenzou, N. C., & Essop, M. F. (2022) · Viruses · doi:10.3390/v14081813 · Cited by 19

Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART

Pantazis, N., Paparizos, V., Papastamopoulos, V., Metallidis, S., Antoniadou, A., Adamis, G., Psichοgiou, M., Chini, M., Sambatakou, H., Chrysos, G., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283648 · Cited by 19

Association of Inflammatory Cytokines and Endothelial Adhesion Molecules with Immunological, Virological, and Cardiometabolic Disease in HIV-Infected Individuals

Lacerda, H. R., Falcão, M. D. C. C., de Albuquerque, V. M. G., Zírpoli, J. C., Miranda-Filho, D. D. B., de Albuquerque, M. D. F. P. M., Montarroyos, U. R., & Ximenes, R. A. D. A. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0029 · Cited by 19

Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study

So‐Armah, K., Quinn, E. K., Cheng, D. M., Tracy, R. P., Baker, J. V., Samet, J. H., & Freiberg, M. S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-399 · Cited by 19

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation

Torres, B., Guardo, A. C., Leal, L., León, A., Lucero, C., Álvarez-Martínez, M. J., Martínez, M. J., Vilà, J., Martínez‐Rebollar, M., Gonzalez‐Cordón, A., et al. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.19246 · Cited by 21

Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease

Ledwaba, L., Tavel, J. A., Khabo, P., Maja, P., Qin, J., Sangweni, P., Liu, X., Follmann, D. A., Metcalf, J. A., Orsega, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0024243 · Cited by 99

Inflammation and Coagulation in HIV Infection Contributes Significantly to Patient Mortality

Stevens, W. S. (2009) · HIV Therapy · doi:10.2217/17584310.3.2.135 · Cited by 1

Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?

So‐Armah, K., Tate, J. P., Chang, C. H., Butt, A. A., Gerschenson, M., Gibert, C. L., Leaf, D. A., Rimland, D., Rodriguez‐Barradas, M. C., Budoff, M. J., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000954 · Cited by 111

Evaluation of Pro-inflammatory and Coagulation Biomarkers among PLHIV on Highly Active Antiretroviral Therapy with Effect of Viral Suppression on them

Yadav, N., Bansal, K., Aggarwal, R., Jain, D., & Yadav, A. (2026) · Journal of the Indian Medical Association · doi:10.5005/jima-1107-124_02_08

Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death

Boulware, D. R., Hullsiek, K. H., Puronen, C. E., Rupert, A. W., Baker, J. V., French, M. A., Bohjanen, P. R., Novak, R. M., Neaton, J. D., & Sereti, I. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir134 · Cited by 314